Nishiyama A, Adachi Y, Tonouchi K, Moriyama S, et al. Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses. Vaccine 2023 Jun 15:S0264-410X(23)00685-0. doi: 10.1016/j.vaccine.2023.
PMID: 37330368